| Trial ID: | L0500 |
| Source ID: | NCT01681303
|
| Associated Drug: |
Ast-120
|
| Title: |
Effect of An Oral Absorbent AST-120 in Late-stage Chronic Kidney Disease (CKD) Patients.
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Kidney Disease|AST-120
|
| Interventions: |
DRUG: AST-120
|
| Outcome Measures: |
Primary: renal function change, 1 year | Secondary: anemia, 1 year | Other: lipid profile and uric acid, 1 year
|
| Sponsor/Collaborators: |
Sponsor: Chang Gung Memorial Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
51
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2009-01
|
| Completion Date: |
2011-12
|
| Results First Posted: |
|
| Last Update Posted: |
2013-08-06
|
| Locations: |
Department of Nephrology, Chang Gung Memorial Hospital, Keelung, 204, Taiwan
|
| URL: |
https://clinicaltrials.gov/show/NCT01681303
|
